Ongoing Disclosure Notice – David Banfield

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Comvita Limited
Date this disclosure made:
28-Sep-21
Date of last disclosure:
1-Sep-21
Director or senior manager giving disclosure
Full name(s):
David Robert Banfield
Name of listed issuer:
Comvita Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
CEO and Managing Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary shares
Performance share rights
Nature of the affected relevant interest(s):
Registered Holder
For that relevant interest-
Number held in class before acquisition or disposal:
521,561 ordinary shares (184,073 held by David
Banfield and 337,488 held on behalf of the David
and Joy Banfield Trust
106,213 performance share rights
Number held in class after acquisition or disposal:
533,392 ordinary shares (195,904 held by David
Banfield and 337,488 held on behalf of the David
and Joy Banfield Trust
94,382 performance share rights
Current registered holder(s):
David Banfield, Joy Banfield and Julian Donald as
trustees for the David and Joy Banfield Trust
Registered holder(s) once transfers are registered:
David Banfield
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:
1
Details of transactions requiring disclosure-
Date of transaction:
28-Sep-21
Nature of transaction:
11,831 shares issued under the Comvita Limited
Performance Share Rights Scheme
Name of any other party or parties to the transaction (if known):
Comvita Limited
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:Nil
Number of financial products to which the transaction related:
11,831 ordinary shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:
No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Date of the prior written clearance (if any):
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all persons
for whom it is made.
Signature of director or officer:
Date of signature:
28-Sep-21
DocuSign Envelope ID: B8C42E42-A87D-4E58-BE83-C8D32932B772